[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Stryker Corp (SYK)

Stryker Corp (SYK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Can Stryker Justify Optimism After Cyber Disruption and Implant Demand Softness?

Stryker Corporation (SYK) reports second-quarter 2026 earnings after market close on July 30, 2026, with investors focused on whether the medical technology leader can rebound from last quarter's significant miss. The central question: can Stryker return to its historical pattern of beating estimates, or will the disappointing Q1 performance signal deeper challenges in the business? With analyst estimates rising sharply and the stock trading near $352, this report will test investor confidence in the company's growth trajectory.

Stryker Corporation is a leading medical technology company specializing in orthopedics, medical and surgical equipment, and neurotechnology products. The company serves healthcare providers globally with products ranging...

Fundamentals

See More
  • Market Capitalization, $K 135,038,912
  • Shares Outstanding, K 383,361
  • Annual Sales, $ 25,116 M
  • Annual Income, $ 3,246 M
  • EBIT $ 5,733 M
  • EBITDA $ 6,926 M
  • 60-Month Beta 0.77
  • Price/Sales 5.29
  • Price/Cash Flow 20.52
  • Price/Book 5.78

Options Overview Details

View History
  • Implied Volatility 38.84% (+0.67%)
  • Historical Volatility 41.95%
  • IV Percentile 98%
  • IV Rank 93.10%
  • IV High 40.43% on 07/20/26
  • IV Low 17.47% on 08/12/25
  • Expected Move (DTE 22) 22.85 (6.61%)
  • Put/Call Vol Ratio 0.74
  • Today's Volume 148
  • Volume Avg (30-Day) 1,117
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 35,903
  • Open Int (30-Day) 34,421
  • Expected Range 322.80 to 368.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $3.46
  • Number of Estimates 7
  • High Estimate $3.61
  • Low Estimate $3.36
  • Prior Year $3.13
  • Growth Rate Est. (year over year) +10.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
306.53 +12.65%
on 07/14/26
352.49 -2.04%
on 07/29/26
+30.48 (+9.68%)
since 06/30/26
3-Month
281.00 +22.89%
on 05/11/26
352.49 -2.04%
on 07/29/26
+30.18 (+9.58%)
since 04/30/26
52-Week
281.00 +22.89%
on 05/11/26
401.99 -14.10%
on 07/31/25
-55.10 (-13.76%)
since 07/30/25

Most Recent Stories

More News
Can Stryker Justify Optimism After Cyber Disruption and Implant Demand Softness?

Barchart Research What to Expect from SYK Earnings SYK Generated July 29, 2026 Current Price $352.25 EPS Estimate $$3.46 Consensus Rating Moderate Buy Average Move 2.78% Can Stryker Justify Optimism After...

SYK : 346.92 (-1.51%)
Stryker (SYK) Q2 Earnings Report Preview: What To Look For

Stryker (SYK) Q2 Earnings Report Preview: What To Look For

SYK : 346.92 (-1.51%)
Stryker expands Mako robotics portfolio with full market release of Mako RPS

New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic market

SYK : 346.92 (-1.51%)
Stryker's Quarterly Earnings Preview: What You Need to Know

Stryker is set to post its second-quarter results later this month, and analysts project a double-digit earnings growth.

ABT : 105.58 (-2.24%)
XLV : 163.01 (-1.94%)
SYK : 346.92 (-1.51%)
$SPX : 7,385.70 (+0.95%)
1 Cash-Producing Stock Worth Your Attention and 2 Facing Challenges

1 Cash-Producing Stock Worth Your Attention and 2 Facing Challenges

SYK : 346.92 (-1.51%)
CLB : 10.24 (+3.75%)
BKR : 59.71 (+1.69%)
Stryker to announce second quarter 2026 financial results

Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026 , to discuss its second quarter 2026 financial results....

SYK : 346.92 (-1.51%)
Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement

PORTAGE, Mich. , June 24, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, today announced a new partnership with Major Champion and globally recognized golfer Shane...

SYK : 346.92 (-1.51%)
3 of Wall Street’s Favorite Stocks to Consider Right Now

3 of Wall Street’s Favorite Stocks to Consider Right Now

SYK : 346.92 (-1.51%)
VRTX : 474.46 (-1.84%)
CASH : 88.20 (-0.75%)
3 Big Reasons SYK Should Be On Your Watchlist

3 Big Reasons SYK Should Be On Your Watchlist

SYK : 346.92 (-1.51%)
When Investors Finally Get Sick of AI Stocks, This Medical Devices ETF Could Be a Long-Term Winner

Over the long term, the IHI ETF looks like a good turnaround story.

ABT : 105.58 (-2.24%)
SYK : 346.92 (-1.51%)
IHI : 52.53 (-1.44%)
ISRG : 350.60 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products...

See More

Key Turning Points

3rd Resistance Point 365.09
2nd Resistance Point 358.79
1st Resistance Point 355.52
Last Price 346.92
1st Support Level 345.95
2nd Support Level 339.65
3rd Support Level 336.38

See More

52-Week High 401.99
Fibonacci 61.8% 355.77
Last Price 346.92
Fibonacci 50% 341.49
Fibonacci 38.2% 327.22
52-Week Low 281.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.